MoneyWorks4Me

Sequent Scientific - Quaterly Results

20 May 2025 Evaluate
The March 2025 quarter revenue stood at Rs. 423.30 millions, up 15.12% as compared to Rs. 367.70 millions during the corresponding quarter last year.Modest increase of 12.50% in the Net Profit was reported from. 37.60 millions to Rs. 42.30  millions.The company reported a good operating profit of 94.50 millions compared to 72.40 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 423.30 367.70 15.12 1782.60 1685.20 5.78 1782.60 1685.20 5.78
Other Income 122.70 129.80 -5.47 509.40 459.80 10.79 509.40 459.80 10.79
PBIDT 94.50 72.40 30.52 395.60 193.20 104.76 395.60 193.20 104.76
Interest 9.90 10.30 -3.88 39.60 43.60 -9.17 39.60 43.60 -9.17
PBDT 82.10 62.10 32.21 307.20 87.10 252.70 307.20 87.10 252.70
Depreciation 23.00 21.10 9.00 86.70 89.40 -3.02 86.70 89.40 -3.02
PBT 59.10 41.00 44.15 220.50 -2.30 -9686.96 220.50 -2.30 -9686.96
TAX 16.80 3.40 394.12 62.50 -8.60 -826.74 62.50 -8.60 -826.74
Deferred Tax 5.70 3.40 67.65 23.70 -13.20 -279.55 23.70 -13.20 -279.55
PAT 42.30 37.60 12.50 158.00 6.30 2407.94 158.00 6.30 2407.94
Equity 500.60 498.90 0.34 500.60 498.90 0.34 500.60 498.90 0.34
PBIDTM(%) 22.32 19.69 13.38 22.19 11.46 93.57 22.19 11.46 93.57
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..